|Articles|July 27, 2017
ICON Acquires Mapi Group
Advertisement
ICON plc-a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries-announced it has acquired the patient-centered health outcomes research and commercialization company, Mapi Group.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
2
Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions
3
SCOPE Summit 2026: ESG Shifts From Reporting Exercise to Vendor Readiness Test in Clinical Operations
4
Regulatory Uncertainty Emerges Across the Drug Development Lifecycle
5